Clorox Company (The) (NYSE:CLX) Position Raised by Moody Lynn & Lieberson LLC

Moody Lynn & Lieberson LLC boosted its position in shares of Clorox Company (The) (NYSE:CLX) by 12.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 2,243 shares of the company’s stock after buying an additional 252 shares during the period. Moody Lynn & Lieberson LLC’s holdings in Clorox Company (The) were worth $299,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. American Beacon Advisors Inc. purchased a new position in shares of Clorox Company (The) during the first quarter worth about $104,000. Quadrant Capital Group LLC boosted its position in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock worth $106,000 after buying an additional 158 shares during the period. Valley National Advisers Inc. boosted its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. boosted its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the period. Finally, Zions Bancorporation boosted its position in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock worth $134,000 after buying an additional 53 shares during the period. 70.29% of the stock is currently owned by institutional investors and hedge funds.

Shares of Clorox Company (NYSE:CLX) opened at 134.49 on Monday. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The company has a market cap of $17.32 billion, a PE ratio of 26.57 and a beta of 0.40. The firm’s 50 day moving average is $134.79 and its 200-day moving average is $133.07.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business’s quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the company posted $1.30 EPS. Equities analysts expect that Clorox Company will post $5.69 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This story was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://stocknewstimes.com/2017/08/07/clorox-company-the-nyseclx-position-raised-by-moody-lynn-lieberson-llc.html.

A number of brokerages recently issued reports on CLX. UBS AG reissued a “sell” rating and issued a $121.00 price objective (up from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. BMO Capital Markets set a $150.00 price objective on shares of Clorox Company (The) and gave the company a “buy” rating in a research note on Thursday. Zacks Investment Research cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $129.13.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply